Journal
Article title
Selected contents from this journal
Title variants
Languages of publication
Abstracts
Neurosteroids have long been known to act as important modulators of central nervous system functions. The concept of their mechanism of action, however, have essentially undergone an evolution. Previously, these compounds were postulated to regulate neuronal function mainly via allosteric regulation of some membrane-bound receptors, such as GABAA and NMDA receptors, in a non-genomic way. Recent studies have provided evidence for intracellular targets for neurosteroids, e.g., transcription factors (NFkappa-B, progesterone receptors), protein kinases (phosphatidylinositol 3-kinase, protein kinase C), or microtubule-associated proteins, i.e. factors essential in regulation of neuronal survival and apoptosis. This paper reviews in vitro and in vivo data on neurosteroid involvement in the regulation of neurodegenerative processes with emphasis on new intracellular and genomic mechanisms of their action. Potential utility of neurosteroids in the treatment of some neurodegenerative disorders has been also discussed.
Year
Volume
Issue
Pages
359-367
Physical description
Contributors
author
author
author
author
author
author
References
Document Type
REVIEW
Publication order reference
Wladyslaw Lason, Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Science, Smetna 12, 31-343 Krakow, Poland
Identifiers
YADDA identifier
bwmeta1.element.element-from-psjc-03e0147f-deb5-318e-9f81-3df008eb7427